No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Anti-Bacterial Agents / adverse effects
-
Anti-Bacterial Agents / therapeutic use*
-
Cefepime
-
Cephalosporins / administration & dosage
-
Cephalosporins / adverse effects*
-
Cephalosporins / therapeutic use
-
Escherichia coli / drug effects
-
Escherichia coli / enzymology
-
Escherichia coli Infections / drug therapy
-
Escherichia coli Infections / epidemiology
-
Female
-
Hospitalization / statistics & numerical data*
-
Humans
-
India / epidemiology
-
Klebsiella Infections / drug therapy
-
Klebsiella Infections / epidemiology
-
Klebsiella pneumoniae / drug effects
-
Klebsiella pneumoniae / isolation & purification
-
Male
-
Middle Aged
-
Penicillanic Acid / administration & dosage
-
Penicillanic Acid / adverse effects
-
Penicillanic Acid / analogs & derivatives*
-
Penicillanic Acid / therapeutic use
-
Piperacillin / therapeutic use
-
Tazobactam
-
Treatment Outcome
-
Young Adult
-
beta-Lactamases / biosynthesis
-
beta-Lactamases / drug effects
Substances
-
Anti-Bacterial Agents
-
Cephalosporins
-
Cefepime
-
Penicillanic Acid
-
beta-Lactamases
-
Tazobactam
-
Piperacillin